MedPath

Study on the efficacy of traditional Chinese medicine in the treatment of nonarteritis anterior ischemic optic neuropathy

Phase 1
Conditions
nonarteritic anterior ischemic optic neuropathy
Registration Number
ITMCTR2022000062
Lead Sponsor
Eye Hospital of China Academy of Chinese Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

(1) Comply with the diagnostic criteria of western medicine and traditional Chinese medicine;
(2) Age 50-80 years old, gender is not limited;
(3) The course of the disease is 1-5 months; if the patient has the onset of both eyes successively and the onset time of both eyes is 1-5 months, the latter eye will be selected and included in the group;
(4) Good control of blood pressure and blood sugar;
(5) Not participating in other clinical trials during treatment;
(6) Patients volunteered to participate in this research.

Exclusion Criteria

(1) Arteritis anterior ischemic optic neuropathy is excluded;
(2) Hormone therapy has been used within one week before enrollment;
(3) Suffering from other eye diseases or diopter exceeding ±6.00DS;
(4) Patients with recurrent NAION in one eye;
(5) Combined with other eye diseases;
(6) suffering from mental or neurological diseases;
(7) Dysfunction of important organs such as the heart, liver and kidney;
(8) Suffering from malignant tumor;
(9) Pregnant or lactating women;
(10) Participating in other relevant clinical investigators;
(11) Patients who refuse to sign informed consent.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
vision ;
Secondary Outcome Measures
NameTimeMethod
optical coherence tomography;visual field;
© Copyright 2025. All Rights Reserved by MedPath